Italy
AnaCap buys €700m UniCredit loan portfolio
AnaCap Financial Partners is understood to have acquired a €700m portfolio of non-performing loans from UniCredit Credit Management Bank (UCCMB), the debt collection unit of UniCredit.
HIG Capital appoints MD of new Italian office
Raffaele Legnani, HIG Capital
United Ventures holds second close on €50m
Italian venture capital firm United Ventures has held a second close on more than €50m with the support of the European Investment Fund (EIF).
CoBe Capital buys Hatria from Marazzi
CoBe Capital has acquired Italian ceramics company Hatria from Marazzi Group, owned by NYSE-listed Mohawk Industries.
Hutton Collins injects €50m into Dedalus
Hutton Collins has made a €50m investment in Dedalus, an Italian healthcare IT systems provider, along with a further €15m from co-investors.
KKR injects €100m into Gruppo Argenta
KKR has made a debt and equity commitment of around €100m to vending machine firm Gruppo Argenta to stabilise its capital structure and provide growth capital.
Deal in focus: Alto buys Dolciaria Val D'Enza stake
Alto Partners has acquired a 41.88% stake in baked products maker Dolciaria Val D'Enza.
AnaCap buys Monte dei Paschi loan portfolio
AnaCap Financial Partners has acquired a €551m portfolio of performing salary-secured loans from Italian banking group Gruppo Monte dei Paschi di Siena.
Ambienta holds second close on €200.2m
Environmental investor Ambienta has held a second close for Ambienta II on €200.2m.
Italian luxury sector home to strongest European IPO of 2013
Italian luxury
Programma 101 hits first close
Italian venture capital investor Programma 101 (P101) has held a first close of its maiden fund on €32m.
Capvis races off with Riverside's Arena
Swiss mid-market fund Capvis has bought Italy-based aquatic sports brand Arena, founded by the son of Adidas-founder Horst Dassler, from Riverside.
Fondo Italiano backs Forgital Group
Fondo Italiano di Investimento has injected €30m into Forgital Group, an industrial components manufacturer and systems provider.
Fondo Italiano enters entertainment market
Fondo Italiano di Investimento has made its first transaction in the entertainment and events management market with a €10m investment.
Moncler to trade at top end of price range
Italian luxury jacket maker Moncler, backed by Eurazeo, Carlyle and Progressio Investimenti, is to begin trading on Monday at the top end of its price range.
PEP and Keyhaven launch co-investment partnership
Italian GP Private Equity Partners (PEP) and London-based private equity firm Keyhaven Capital Partners have launched a co-investment partnership.
EmCap buys stake in Moretti
Newly launched investor EmCap has acquired a minority stake in Italian luxury shoemaker Alberto Moretti, marking the GP’s maiden investment.
Italian association berates "unnecessarily heavy" tax changes
Aifi, the Italian private equity association, has criticised changes to corporate taxation structures that could see the beleaguered industry take another hit.
Deal in focus: Ardian and Consilium sell Rollon
In mid-November, after almost a year of negotiations, Ardian and Consilium sold Rollon, an Italian manufacturer of liner rails and actuators, to French GP Chequers Capital and Italian investor IGI.
Ergon's Nicotra Gebhardt buys Industrie CBI
Nicotra Gebhardt, a centrifugal fan maker backed by Ergon Capital Partners, has acquired Italian industrial fan producer Industrie CBI.
Italian dealflow wakes from slumber
Italian dealflow
Eurazeo to divest 12% stake in Moncler IPO
Eurazeo, one of the backers of Italian clothing manufacturer Moncler, will see its stake reduced to 19.7% following the company's upcoming IPO.
Moncler sets IPO price range
Italian luxury down jacket maker Moncler, backed by Eurazeo, Carlyle Group and Progressio Investimenti, has priced its listing on the Mercato Telematico Azionario at €8.75-10.2 per share.
Sofinnova Partners et al. sell EOS for up to €310m
Sofinnova Partners, Aescap Venture and Principia have sold Milan-based cancer therapeutics firm Ethical Oncology Science (EOS) to Clovis Oncology via an agreement that could see the firm fetch up to €310m.